These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 16383287)

  • 1. [Targeted therapy of neoplasms and pharmacopathology].
    Zhu XZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):468-70. PubMed ID: 16383287
    [No Abstract]   [Full Text] [Related]  

  • 2. CD20-targeted therapy: a breakthrough in the treatment of non-Hodgkin's lymphoma.
    van Meerten T; Hagenbeek A
    Neth J Med; 2009; 67(7):251-9. PubMed ID: 19687518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 4. Targeted delivery of tissue factor to tumor neovasculature for cancer therapy.
    Neri D
    Haemostasis; 2001; 31 Suppl 1():21-2. PubMed ID: 11990467
    [No Abstract]   [Full Text] [Related]  

  • 5. Mixed results for novel CD20-targeted antibody.
    Nat Rev Drug Discov; 2009 Oct; 8(10):762. PubMed ID: 19794435
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeted therapies for cancer.
    McKay M
    Aust Fam Physician; 2008 Apr; 37(4):201. PubMed ID: 18488301
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeted therapies: a nursing perspective.
    Kay P
    Semin Oncol Nurs; 2006 Feb; 22(1 Suppl 1):1-4. PubMed ID: 16616280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of drug-carrying immunoliposomes as anticancer agents. Commentary re: J. W. Park et al., Anti-HER2 immunoliposomes: enhanced efficacy due to targeted delivery. Clin. Cancer Res., 8: 1172-1181, 2002.
    Siwak DR; Tari AM; Lopez-Berestein G
    Clin Cancer Res; 2002 Apr; 8(4):955-6. PubMed ID: 11948099
    [No Abstract]   [Full Text] [Related]  

  • 9. HER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy.
    Alexis F; Basto P; Levy-Nissenbaum E; Radovic-Moreno AF; Zhang L; Pridgen E; Wang AZ; Marein SL; Westerhof K; Molnar LK; Farokhzad OC
    ChemMedChem; 2008 Dec; 3(12):1839-43. PubMed ID: 19012296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Target-oriented tumor therapy -- proof of the principle].
    Gastl G; Hiddemann W
    Dtsch Med Wochenschr; 2004 Oct; 129(40):2093. PubMed ID: 15455299
    [No Abstract]   [Full Text] [Related]  

  • 11. [Breast cancer: adjuvant therapy with trastuzumab: herceptin adjuvant (HERA) Trial Study, B-31- and N9831-Study].
    Mallmann P
    Internist (Berl); 2006 Nov; 47(11):1183-5. PubMed ID: 17048017
    [No Abstract]   [Full Text] [Related]  

  • 12. Targeted cancer therapeutics: the heartbreak of success.
    Mann DL
    Nat Med; 2006 Aug; 12(8):881-2. PubMed ID: 16892027
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoconjugates in drug delivery systems.
    Cannon JB; Hui HW
    Targeted Diagn Ther; 1990; 3():121-39. PubMed ID: 2131008
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trastuzumab treatment for breast cancer].
    Yamashiro H; Toyama K; Bando H; Saji S; Toi M
    Nihon Rinsho; 2004 Jul; 62(7):1305-11. PubMed ID: 15283148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Development of monoclonal antibody therapy for brain tumors].
    Mishima K
    Nihon Rinsho; 2005 Sep; 63 Suppl 9():569-77. PubMed ID: 16201583
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current status and prospect of neoplasm targeted therapy].
    Wang Y; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):638-40. PubMed ID: 16438880
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in therapy for solid tumors: potential for overcoming drug resistance in vivo with molecular targeting agents.
    Kim R; Toge T
    Surg Today; 2004; 34(4):293-303. PubMed ID: 15052442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aiming for a direct hit: combining molecular imaging with targeted cancer therapy.
    Reilly RM
    J Nucl Med; 2009 Jul; 50(7):1017-9. PubMed ID: 19525475
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeting tumors with nanobodies for cancer imaging and therapy.
    Oliveira S; Heukers R; Sornkom J; Kok RJ; van Bergen En Henegouwen PM
    J Control Release; 2013 Dec; 172(3):607-17. PubMed ID: 24035975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CML: a model for targeted therapy.
    Cilloni D; Saglio G
    Best Pract Res Clin Haematol; 2009 Sep; 22(3):285-94. PubMed ID: 19959080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.